Bioanalytical Systems

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Research Services and Research Products. The Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

The full company name is Basis Global Technologies Inc - Ordinary Shares - Class A.

WEST LAFAYETTE, Ind., Nov.  08, 2019  (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”), a leading provider of nonclinical and analytical contract research services, today announced that the Company has entered into an agreement to purchase substantially all of the assets of Pre-Clinical Research Services, Inc. (“PCRS”), a premier provider of surgical and medical device contract research services.

BASi Announces Expansion into Surgical Models and Medical Devices with Agreement to Purchase Pre-Clinical Research Services

WEST LAFAYETTE, Ind., Oct.  01, 2019  (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of Stewart B. Jacobson, DVM, DACVP, as Vice President, Pathology, effective October 1, 2019. Dr. Jacobson fills an important scientific leadership position within the Company, which continues to invest in key appointments to the leadership team. 

Stewart B. Jacobson, DVM, DACVP, Joins BASi as Vice President, Pathology, Filling Key Scientific Leadership Position

WEST LAFAYETTE, Ind., Sept.  04, 2019  (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of William D. Pitchford, BS, MA, as Chief Human Resources Officer, effective as of August 28, 2019. Mr. Pitchford fills an important leadership position, as the Company invests in unifying and strengthening its corporate culture following the acquisition of Seventh Wave Laboratories in July of last year and, more recently, the Smithers Avanza Toxicology Services business unit in May.

News for Bioanalytical Systems Stock (BASI)